Example: Heart Attack

Search clinical trials for: Dopamine Agents

Total 3724 results

    • NCT03151460
      Completed
      Dopaminergic Modulation of Declarative Memory
      Conditions: Parkinson's Disease
    • NCT03793491
      Active, not recruiting
      Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT02642315
      Completed
      The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
      Conditions: Restless Legs Syndrome
    • NCT03353025
      Recruiting
      Study on Therapy of Non-invasive Prolactinoma
      Conditions: Prolactinoma
    • NCT03929068
      Suspended
      Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
      Conditions: Amyotrophic Lateral Sclerosis; Motor Neuron Disease
    • NCT04182399
      Recruiting
      Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot Study
      Conditions: Parkinson Disease
    • NCT02812147
      Active, not recruiting
      Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease
      Conditions: Parkinson Disease
    • NCT02109393
      Completed
      Rehabilitation in Patients With Progressive Supranuclear Palsy
      Conditions: Progressive Supranuclear Palsy
    • NCT04228523
      Not yet recruiting
      Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)
      Conditions: Parkinson Disease
    • NCT01944436
      Completed
      A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
      Conditions: Lewy Body Disease
    • NCT04178993
      Recruiting
      Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
      Conditions: Methamphetamine Use Disorder
    • NCT03250117
      Terminated
      Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
      Conditions: Parkinson Disease
    • NCT02634684
      Completed
      Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
      Conditions: Schizophrenia
    • NCT01625897
      Completed
      A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
      Conditions: Schizophrenia
    • NCT01626872
      Completed
      Long-Term Study of MP-214 in Patients With Schizophrenia
      Conditions: Schizophrenia
    • NCT01625000
      Completed
      Safety and Efficacy of MP-214 in Patients With Schizophrenia
      Conditions: Schizophrenia
    • NCT01104766
      Completed
      Safety and Efficacy of Cariprazine in Patients With Schizophrenia
      Conditions: Schizophrenia
    • NCT01117181
      Completed
      Apathy in Dementia Methylphenidate Trial (ADMET)
      Conditions: Apathy; Alzheimer's Disease
    • NCT02533219
      No longer available
      Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
      Conditions: Hyperinsulinemic Hypoglycemia, Persistent; Congenital Hyperinsulinism; Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
    • NCT02431715
      Available
      18F-FDOPA PET in Neuroendocrine Tumours
      Conditions: Thyroid Cancer, Medullary; Carcinoid Tumor; Pheochromocytoma; Paraganglioma; Insulinoma; Neuroblastoma
    • NCT02371031
      Terminated
      FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
      Conditions: Glioma; Malignant Glioma
    • NCT02021604
      Recruiting
      Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
      Conditions: Congenital Hyperinsulinism; Insulinoma
    • NCT02175745
      Terminated
      18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
      Conditions: Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Oligodendroglioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Subependymal Giant Cell Astrocytoma; Childhood High-grade Cerebellar Astrocytoma; Childhood High-grade Cerebral Astrocytoma; Childhood Low-grade Cerebellar Astrocytoma; Childhood Low-grade Cerebral Astrocytoma; Recurrent Adult Brain Tumor; Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma; Recurrent Childhood Anaplastic Oligodendroglioma; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Diffuse Astrocytoma; Recurrent Childhood Fibrillary Astrocytoma; Recurrent Childhood Gemistocytic Astrocytoma; Recurrent Childhood Giant Cell Glioblastoma; Recurrent Childhood Glioblastoma; Recurrent Childhood Gliomatosis Cerebri; Recurrent Childhood Gliosarcoma; Recurrent Childhood Oligoastrocytoma; Recurrent Childhood Oligodendroglioma; Recurrent Childhood Pilomyxoid Astrocytoma; Recurrent Childhood Protoplasmic Astrocytoma; Recurrent Childhood Subependymal Giant Cell Astrocytoma; Recurrent Childhood Visual Pathway and Hypothalamic Glioma; Recurrent Childhood Visual Pathway Glioma; Untreated Childhood Anaplastic Astrocytoma; Untreated Childhood Anaplastic Oligoastrocytoma; Untreated Childhood Anaplastic Oligodendroglioma; Untreated Childhood Brain Stem Glioma; Untreated Childhood Cerebellar Astrocytoma; Untreated Childhood Cerebral Astrocytoma; Untreated Childhood Diffuse Astrocytoma; Untreated Childhood Fibrillary Astrocytoma; Untreated Childhood Gemistocytic Astrocytoma; Untreated Childhood Giant Cell Glioblastoma; Untreated Childhood Glioblastoma; Untreated Childhood Gliomatosis Cerebri; Untreated Childhood Gliosarcoma; Untreated Childhood Oligoastrocytoma; Untreated Childhood Oligodendroglioma; Untreated Childhood Pilomyxoid Astrocytoma; Untreated Childhood Protoplasmic Astrocytoma; Untreated Childhood Subependymal Giant Cell Astrocytoma; Untreated Childhood Visual Pathway and Hypothalamic Glioma; Untreated Childhood Visual Pathway Glioma
    • NCT02104310
      Recruiting
      A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
      Conditions: Malignant Glioma
    • NCT00674440
      Completed
      Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
      Conditions: Congenital Hyperinsulinism; Hyperinsulinism; Persistent Hyperinsulinemic Hypoglycemia of Infancy; CHI; PHHI
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations